Jiangsu Jibeier Pharmaceutical Co., Ltd. was established in November 2001 and registered in Zhenjiang, Jiangsu Province. The company is a high-tech enterprise specialized in drug R & D and manufacture and has formed a diversified product series mainly composed of high-tech products, such as Leucogen Tablets for leukogenic effect, and Nitrendipine and Atenolol Tablets, first class new combination drug for anti hypertension, etc. Jibeier is committed to developing innovative drugs for the treatment of depression, cancer, stomach disease and other diseases.
The company has established a professional R & D team of more than 100 people. It has built a research and development technology platform supported by combination preparation research and development technology, deuterium drug research and development technology, and liposome drug research and development technology, and has started a series of innovative drug research and development work. At present, the company has established "Jiangsu academician workstation", "Jiangsu anti lung cancer and breast cancer Engineering Research Center" and other research and development centers. It has been authorized 12 national invention patents, 1 U.S. patent, and 15 patents are being reviewed; it has obtained 6 new drug certificates, 6 high-tech product certificates and 2 national key new product certificates. Jibeier also participated in the drafting of the national drug quality standard of Leucogen Tablets, Nitrendipine and Atenolol Tablets, Aceclofenac enteric-coated Tablets and other products.
|Full name||Jiangsu Jibeier Pharmaceutical Co., Ltd.|
|Domicile||Zhenjiang City, Jiangsu Province|
|Has weighted voting rights structure?||No|
|Earnings Per Share||0.81||0.69||0.55|
|R&D expenditure as a % of operating revenue||5.74%||4.04%||3.79%|
|Total Owners' Equity||470.46||357.68||440.76|
|Net Cash Flows-Operating||115.45||97.97||111.66|
|Net Cash Flows-Investing||-29.55||-5.29||-19.58|
|Net Cash Flows-Financing||-17.42||-169.14||-24.02|
|Name||No. of Shares Held (mn)||% of Shares Held|
All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.
Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.
Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.